Previous 10 | Next 10 |
2024-02-26 01:44:56 ET Summary Bridgewater Associates' 13F portfolio value increased from ~$16.55B to ~$17.86B in Q4 2023. The top three individual stock positions are Procter & Gamble, Coca-Cola, and Costco. Stake increases include iShares Core S&P 500 ETF, Johnson &a...
2024-02-25 06:27:50 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-02-19 03:22:56 ET Summary McKesson reported 15% topline growth and 12.2% adjusted EPS growth in their recent earnings report. The company's GLP-1 medications have shown impressive growth, contributing 60% to year-over-year growth. McKesson's strong distribution network an...
2024-02-14 10:24:17 ET More on Cardinal Health, Cencora, etc. McKesson Corporation 2024 Q3 - Results - Earnings Call Presentation McKesson Corporation (MCK) Q3 2024 Earnings Call Transcript Cardinal Health, Inc. (CAH) Q2 2024 Earnings Call Transcript Argus up...
2024-02-08 15:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $567.00 for MCK on 2024-02-08 14:29:00. The adjusted price target was set to $567.00. At the time of the announcement, MCK was trading at $494.01. The overall price target consensus is at ...
2024-02-08 06:01:58 ET McKesson Corporation has experienced positive revenue growth in its U.S. Pharmaceutical segment, driven by market growth, higher volumes, and price increases. MCK has incurred significant operating expenses, including restructuring charges and exit costs, due to bus...
2024-02-07 22:30:28 ET Image source: The Motley Fool. McKesson (NYSE: MCK) Q3 2024 Earnings Call Feb 07, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: McKesson (MCK) Q3 2024 Earnings Call Transcript
2024-02-07 19:12:04 ET McKesson Corporation. (MCK) Q3 2024 Earnings Conference Call February 07, 2024, 04:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Chief Financial Officer ...
2024-02-07 16:12:29 ET More on McKesson McKesson: Why The Company Is Too Richly Valued McKesson Q3 2024 Earnings Preview McKesson looking to sell Rexall pharmacy chain in Canada - report Seeking Alpha’s Quant Rating on McKesson Historical earni...
McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results . As previously announced, the company will host a live webcast of t...
News, Short Squeeze, Breakout and More Instantly...
The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its role in advising majo...
2024-04-18 21:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
McKesson Corporation (NYSE: MCK) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 0.98% on the day to $527.78. McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and spec...